Status:
TERMINATED
A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation
Lead Sponsor:
Washington University School of Medicine
Conditions:
Urolithiasis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The older lithotripter, HM3, has over 90% stone-free rate in most studies. However, it's less transportable than the new model, F2. There are no prospective trials performed to make a valid comparison...
Detailed Description
Shock wave kidney stone treatment was introduced in the 1980's. It is the least invasive method to treat kidney stone disease. The unmodified Dornier HM3 has over 90% stone free rate in most studies. ...
Eligibility Criteria
Inclusion
- Patients diagnosed with urolithiasis and choose to have ESWL treatment
- Age 18-90 years old
- Able to understand the informed consent
Exclusion
- Minors
- Cognitively impaired
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00913159
Start Date
November 1 2009
End Date
August 1 2010
Last Update
October 18 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Urology, Washington University School of Medicine
St Louis, Missouri, United States, 63110